Update on Systemic Therapies for Thyroid Cancer

Eric J. Sherman, MD, provides an update on the different subtypes and therapies for thyroid cancer. Dr. Sherman also identifies the FDA approved agents to treat thyroid cancers with RET fusion and TRK fusion, and compendium approved treatment for BRAF mutation driven thyroid cancers.

Back to Symposium Page »


February 20, 2021

Created by

Scripps CME Connection

Related Presenters

Eric Sherman, MD

Eric Sherman, MD

Medical Oncologist, Head and Neck Cancer; Thyroid Cancer
Memorial Sloan Kettering Cancer Center

Dr. Eric Sherman is a medical oncologist dedicated to improving the lives of patients with head and neck cancer. His primary clinical and research focus is on thyroid cancers and squamous cell carcinomas of the head and neck. He also has ...

View full profile